• Aphea.Bio secures €14 million Series B financing to further develop its next generation agricultural biologicals

    Friday November 20th 2020

  • E4/DRSP, a Novel Combined Oral Contraceptive, submitted to Brazilian regulatory authorities

    Tuesday November 17th 2020

  • Biocartis Announces Publication of Large Multi-Center Comparison Study with Idylla™ MSI Assay Showing Very Low Failure Rates and Excellent Concordance with Reference Methods

    Tuesday November 17th 2020

  • icometrix wins EIT Digital Challenge 2020 for Digital Wellbeing

    Tuesday November 17th 2020

  • AbolerIS Pharma Raises €2.5M in Seed Financing from Turenne Santé/Sham Innovation Santé and Newton Biocapital

    Tuesday November 17th 2020

  • Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Venezuela

    Tuesday November 10th 2020

  • Biocartis Announces CE-marking of its Fully Automated Idylla™ SARS-CoV-2 Test

    Tuesday November 10th 2020

  • First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial

    Tuesday November 10th 2020

  • Your news here?

  • Biocair and Roylance Pharma partner to provide end-to-end logistics services

    Tuesday November 10th 2020

  • OXURION NV Confirms New Patents for THR-687 Issued by European and US Patent Offices

    Monday November 9th 2020

  • OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis

    Friday November 6th 2020


Strategic Partners